How do we end Prostate Cancer? Together.

The Journey to ZERO

Three generations fighting for a cure.
A tribute to Bill Schwartz, ZERO's Co-founder and first CEO

Play video

A Story of Hope

ZERO's Heroes ZERO's Heroes

Who are we fighting for?

ZERO's Heroes

You are not alone! We welcome everyone who has been touched by prostate cancer including patients, survivors, loved ones, caregivers, and medical professionals to join us as warriors in our fight against prostate cancer.

With each personal story, our ZERO’s Heroes raise awareness and shed light on the journey to end prostate cancer. Meet some of the patients and families whom we are fighting for 365 days of the year and join our community!

View their stories Tell us your story

ZERO's Impact

Where the money goes


0

Men helped with the assistance of our Co-Pay Program.

0

Men tested for free with our mobile testing units.

0

Education materials provided to men and families.

0

Men are alive due to reduced prostate cancer mortality rates.

quote

I am thankful beyond words for the financial assistance provided by ZERO. It has enabled me to receive life-extending prostate cancer treatment. I now have the gift of time to spend with my wife and three young grandchildren, who I never believed I would see grow up.


Charles Sweeney, Prostate Cancer Patient
quotee

News & Updates

Stay up to date with the latest on ZERO and Prostate Cancer.


screen-shot-2016-12-05-at-1-40-33-pm

Shocking Prostate Tumor with Testosterone ‘Cures’ Man...

A radical therapy is showing promising results in the fight against prostate cancer. At a medical symposium in Europe last ...
screen-shot-2016-11-29-at-1-14-06-pm

Computer Modeling Could Lead to New Method for Detecting, Managin...

New research coauthored by Brigham Young University researchers may lead to a more accurate system for early detection, diagnosis, and ...
screen-shot-2016-12-05-at-2-41-17-pm

Novel Technique May Help Some Patients with Prostate Cancer Avoid...

MRI–guided focal therapy, a novel tumor-destroying technology, is being investigated at Brigham and Women’s Hospital to spare patients with prostate ...
thinkstockphotos543554644_1037942

Looking to the Genome for Prostate Cancer Biomarkers

Oncologists cannot yet predict which men with castration-resistant prostate cancer (CRPC) will benefit from taxane therapy, and which will benefit ...

View all news stories